Cargando…

Radiolabeling Strategies of Nanobodies for Imaging Applications

Nanobodies are small recombinant antigen-binding fragments derived from camelid heavy-chain only antibodies. Due to their compact structure, pharmacokinetics of nanobodies are favorable compared to full-size antibodies, allowing rapid accumulation to their targets after intravenous administration, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Küppers, Jim, Kürpig, Stefan, Bundschuh, Ralph A., Essler, Markus, Lütje, Susanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471529/ https://www.ncbi.nlm.nih.gov/pubmed/34573872 http://dx.doi.org/10.3390/diagnostics11091530

Ejemplares similares

Therapy of Patients with Neuroendocrine Neoplasia—Evidence-Based Approaches and New Horizons
por: Bundschuh, Ralph A., et al.
Publicado: (2019)

Ethanol effects on (68)Ga-radiolabelling efficacy and radiolysis in automated synthesis utilizing NaCl post-processing
por: Meisenheimer, Michael, et al.
Publicado: (2019)

Evaluating a Machine Learning Tool for the Classification of Pathological Uptake in Whole-Body PSMA-PET-CT Scans
por: Erle, Annette, et al.
Publicado: (2021)

Theranostics in nuclear medicine practice
por: Yordanova, Anna, et al.
Publicado: (2017)

Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with (177)Lu-PSMA
por: Moazemi, Sobhan, et al.
Publicado: (2021)

Machine Learning Facilitates Hotspot Classification in PSMA-PET/CT with Nuclear Medicine Specialist Accuracy
por: Moazemi, Sobhan, et al.
Publicado: (2020)

Nanobody-Based Theranostic Agents for HER2-Positive Breast Cancer: Radiolabeling Strategies
por: Hrynchak, Ivanna, et al.
Publicado: (2021)

Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
por: D’Huyvetter, Matthias, et al.
Publicado: (2014)

Decision-support for treatment with (177)Lu-PSMA: machine learning predicts response with high accuracy based on PSMA-PET/CT and clinical parameters
por: Moazemi, Sobhan, et al.
Publicado: (2021)

Biodistribution and post-therapy dosimetric analysis of [(177)Lu]Lu-DOTA(ZOL) in patients with osteoblastic metastases: first results
por: Khawar, Ambreen, et al.
Publicado: (2019)

Uptake of PSMA-ligands in normal tissues is dependent on tumor load in patients with prostate cancer
por: Gaertner, Florian C., et al.
Publicado: (2017)

DOTA-ZOL: A Promising Tool in Diagnosis and Palliative Therapy of Bone Metastasis—Challenges and Critical Points in Implementation into Clinical Routine
por: Meisenheimer, Michael, et al.
Publicado: (2020)

Nanobodies: Chemical Functionalization Strategies and Intracellular Applications
por: Schumacher, Dominik, et al.
Publicado: (2018)

Antibody and Nanobody Radiolabeling with Copper-64: Solid vs. Liquid Target Approach
por: Hrynchak, Ivanna, et al.
Publicado: (2023)

Affimers and nanobodies as molecular probes and their applications in imaging
por: Cordell, Paul, et al.
Publicado: (2022)

In Vivo Tracking of Extracellular Vesicles by Nuclear Imaging: Advances in Radiolabeling Strategies
por: Almeida, Sara, et al.
Publicado: (2020)

High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data
por: Bundschuh, Ralph A., et al.
Publicado: (2023)

Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and Applications
por: Fu, Ruisi, et al.
Publicado: (2018)

A Novel Radiomics-Based Tumor Volume Segmentation Algorithm for Lung Tumors in FDG-PET/CT after 3D Motion Correction—A Technical Feasibility and Stability Study
por: Bundschuh, Lena, et al.
Publicado: (2022)

Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology
por: Pijeira, Martha Sahylí Ortega, et al.
Publicado: (2022)

Radiolabeling Strategies for Tumor-Targeting Proteinaceous Drugs
por: Sugiura, Grant, et al.
Publicado: (2014)

Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging
por: Bernard-Gauthier, Vadim, et al.
Publicado: (2015)

Radiolabeled Nanoparticles for Multimodality Tumor Imaging
por: Xing, Yan, et al.
Publicado: (2014)

Radiolabeling of Nanoparticles and Polymers for PET Imaging
por: Stockhofe, Katharina, et al.
Publicado: (2014)

Radiolabeled Antibodies for Cancer Imaging and Therapy
por: Parakh, Sagun, et al.
Publicado: (2022)

Radiolabeled Liposomes for Nuclear Imaging Probes
por: Low, Ho Ying, et al.
Publicado: (2023)

Radiolabeled Dendrimers for Nuclear Medicine Applications
por: Zhao, Lingzhou, et al.
Publicado: (2017)

Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide–Cysteine Chemistry
por: Chigoho, Dora Mugoli, et al.
Publicado: (2021)

Radiolabelling of Extracellular Vesicles for PET and SPECT imaging
por: Khan, Azalea A., et al.
Publicado: (2021)

The Application of Nanobody in CAR-T Therapy
por: Bao, Chaolemeng, et al.
Publicado: (2021)

Radiolabeled PET/MRI Nanoparticles for Tumor Imaging
por: Forte, Ernesto, et al.
Publicado: (2019)

Molecular imaging of hypoxia with radiolabelled agents
por: Mees, Gilles, et al.
Publicado: (2009)

Radiolabeled Gold Nanoparticles for Imaging and Therapy of Cancer
por: Silva, Francisco, et al.
Publicado: (2020)

Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies
por: Malviya, G., et al.
Publicado: (2009)

Antihormone treatment differentially regulates PSA secretion, PSMA expression and (68)Ga–PSMA uptake in LNCaP cells
por: Mathy, C. S., et al.
Publicado: (2021)

Review of Therapeutic Applications of Radiolabeled Functional Nanomaterials
por: Jeon, Jongho
Publicado: (2019)

Nanobody: The “Magic Bullet” for Molecular Imaging?
por: Chakravarty, Rubel, et al.
Publicado: (2014)

Nanobodies as non-invasive imaging tools
por: Rashidian, M., et al.
Publicado: (2020)

Applications of nanobodies in plant science and biotechnology
por: Wang, Wenyi, et al.
Publicado: (2020)

Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor–Directed Molecular Imaging and Therapy
por: Serfling, Sebastian E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d0p4v6reofi4l9ir9p9lbi65q9